Invitrogen™ Human TrkA ELISA Kit

Ref.: BL-RE-094057Manufacturer ref.: EH466RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human TrkA quantitates human TrkA in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TrkA.

Accession number
C80751 ; DKFZp781I14186 ; EC 2.7.10.1 ; gp140trk ; récepteur de facteur de croissance nerveuse à haute affinité ; kinase TrkA ; MTC ; récepteur neurotrophique tyrosine kinase 1 ; récepteur de tyrosine kinase neurotrophique de type 1 ; tyrosine kinase neurotrophique, récepteur, type 1 ; Ntrk1 ; Oncogene TRK ; p140-TrkA ; récepteur du facteur de croissance nerveuse lente ; Tkr ; trk ; TRK1 ; protéine tyrosine kinase transformatrice de la TRK1 ; TRKA ; trk-A ; récepteur des neurotrophines TrkA ; récepteur proto-oncogene trkA ; Kinase A liée à la tropomyosine ; récepteur de la tyrosine kinase ; récepteur de la tyrosine kinase A
Dose range
2 to 500 pg/ml
Sensitivity of the dosage
2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human TrkA quantitates human TrkA in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TrkA.

Human TrkA quantitates human TrkA in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TrkA.

TrkA (tropomyosin kinase A receptor) code for a member of the neurotrophic tyrosine kinase receptor family (NTKR). TrkA is a membrane receptor that, when neurotrophins are bound, phosphoryles itself and phosphorys members of the MAPK pathway. The presence of TrkA induces cell differentiation and can play a role in the specification of sensory neuron subtypes. TrkA mutations have been associated with congenital insensitivity to pain, anhidrose, self-harm, mental retardation, and cancer. Other splicing variants of this gene have been detected, but only three have been characterized to date. TRKA mutations have been associated with congenital insensitivity to pain, anhidrose, self-mutilation, mental retardation, and cancer.

Sensitivity

Sensitivity of the dosage: 2 ng/ml.

Measurement range

Dose range: 2 to 500 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: TrkA.

Samples

Sample type: Plasma, Serum, Surnatant (Serum volume, 50 µl; supernatant, 50 µl; plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17195249
Specifications
Accession numberC80751; DKFZp781I14186; EC 2.7.10.1; gp140trk; high affinity nerve growth factor receptor; TrkA kinase; MTC; tyrosine kinase 1 neurotrophic receptor; tyrosine kinase type 1 neurotrophic receptor; tyrosine kinase type 1 neurotrophic receptor; Ntrk1; Oncog
Dose range2 to 500 pg/ml
Sensitivity of the dosage2 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P04629
Gene symbol(s)Ntrk1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetTrkA
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; supernatant, 50 µl; plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH466RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.